Literature DB >> 31055983

Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria.

Shio-Shin Jean1,2, Shun-Chung Hsueh3, Wen-Sen Lee4, Po-Ren Hsueh5,6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31055983     DOI: 10.1080/14787210.2019.1612240

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


× No keyword cloud information.
  6 in total

Review 1.  Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.

Authors:  David Aguilera-Alonso; Luis Escosa-García; Jesús Saavedra-Lozano; Emilia Cercenado; Fernando Baquero-Artigao
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

2.  Estimating the size of the United States market for new antibiotics with activity against carbapenem-resistant Enterobacteriaceae.

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

Review 3.  Harnessing Iron Acquisition Machinery to Target Enterobacteriaceae.

Authors:  Artur Sargun; Romana R Gerner; Manuela Raffatellu; Elizabeth M Nolan
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

4.  Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives.

Authors:  Davide Fiore Bavaro; Alessandra Belati; Lucia Diella; Monica Stufano; Federica Romanelli; Luca Scalone; Stefania Stolfa; Luigi Ronga; Leonarda Maurmo; Maria Dell'Aera; Adriana Mosca; Lidia Dalfino; Salvatore Grasso; Annalisa Saracino
Journal:  Antibiotics (Basel)       Date:  2021-05-29

Review 5.  Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis.

Authors:  Giovanni Stelitano; José Camilla Sammartino; Laurent Roberto Chiarelli
Journal:  Molecules       Date:  2020-03-09       Impact factor: 4.411

Review 6.  Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia.

Authors:  Shio-Shin Jean; Yin-Chun Chang; Wei-Cheng Lin; Wen-Sen Lee; Po-Ren Hsueh; Chin-Wan Hsu
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.